Phase II MEDI4736 in Combination With Chemotherapy for First-Line Treatment of Unresectable Mesothelioma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
20 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University San Diego Moores Cancer Center
La Jolla, California, United States
- Ronald Reagan Ucla Medical Center
Los Angeles, California, United States
- Stanford Cancer Institute
Stanford, California, United States
- University of Colorado, Anschutz Cancer Pavilion
Aurora, Colorado, United States
- University of Miami Hospital
Miami, Florida, United States
- Winship Cancer Institute of Emory University
Atlanta, Georgia, United States
- University of Chicago Medical Center
Chicago, Illinois, United States
- Northshore University Healthsystem
Evanston, Illinois, United States
- Johns Hopkins Sidney Kimmel Comprehensive Cancer Center
Baltimore, Maryland, United States
- St. Joseph Mercy Hospital
Ann Arbor, Michigan, United States
- Metro Minnesota Community Oncology Research Consortium
Saint Louis Park, Minnesota, United States
- Washington University in St Louis
St Louis, Missouri, United States
- Rutgers Cancer Institute of New Jersey
New Brunswick, New Jersey, United States
- New York University Laura and Isaac Perlmutter Cancer Center
New York, New York, United States
- Fox Chase Cancer Center
Philadelphia, Pennsylvania, United States
- Hillman Cancer Center Research Pavilion
Pittsburgh, Pennsylvania, United States
- Utsw Medical Center
Dallas, Texas, United States
- Virginia Cancer Specialists
Fairfax, Virginia, United States
- University of Washington Seattle Cancer Care Alliance
Seattle, Washington, United States
- Aurora Cancer Center
Wauwatosa, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 13 Jun 2017
- Primary completion
- 16 Feb 2020
- Completion
- 29 Jun 2023
- Last update posted
- 5 Jul 2023
- Registered enrollment
- 55
- Registry id
- NCT02899195
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.